COLL
Collegium Pharmaceutical, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website collegiumpharma.com
- Employees(FY) 207
- ISIN US19459J1043
Performance
-14.24%
1W
-8.28%
1M
-0.34%
3M
+29.26%
6M
+5.49%
YTD
+42.23%
1Y
Profile
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
Investment Analysis Report: COLL
Overview
In this investment analysis report, we will delve into a comprehensive evaluation of COLL, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operatin...
Technical Analysis of COLL 2024-05-10
Overview:
In analyzing the technical indicators for COLL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.
Trend Anal...
Recent News & Updates
- 2024-05-13 09:31
- 2024-05-13 08:00
- 2024-05-12 20:00
- 2024-05-10 14:01
Collegium Pharmaceutical Reports First Quarter 2024 Earnings(GuruFocus.com)
- 2024-05-10 12:17
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024(Associated Press Finance)
- 2024-05-10 09:51
- 2024-05-10 06:11
- 2024-05-10 04:48
- 2024-05-09 18:00
- 2024-05-09 17:40
- 2024-05-09 16:36
Collegium Pharmaceutical: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-09 16:02
Collegium Reports First Quarter 2024 Financial Results(GlobeNewswire)
- 2024-05-09 16:01
Collegium Announces CEO Transition(GlobeNewswire)
- 2024-05-09 06:00
- 2024-05-09 05:40
- 2024-05-09 04:02
Collegium Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-05-09 04:01
Collegium Announces CEO Transition(Globenewswire)
- 2024-05-07 09:15
- 2024-05-06 21:15
- 2024-05-02 10:01
- 2024-05-01 22:01
- 2024-04-29 09:45
- 2024-04-29 08:00
- 2024-04-28 21:45
- 2024-04-28 20:00
- 2024-04-25 08:00
- 2024-04-24 20:00
- 2024-04-23 20:00
COLL: Rating increased to a BUY(Argus Research)
- 2024-04-17 08:13
- 2024-04-11 08:00
Page 1 of 6
previousnext